BFI Co., LLC 4
4 · PHIBRO ANIMAL HEALTH CORP · Filed Aug 8, 2018
Insider Transaction Report
Form 4
BFI Co., LLC
10% Owner
Transactions
- Sale
Class A Common Stock
2018-08-06$50.66/sh−10,000$506,600→ 8,000 total - Conversion
Class B Common Stock
2018-08-07+12,000→ 20,306,034 totalExercise: $0.00→ Class A Common Stock (12,000 underlying) - Sale
Class A Common Stock
2018-08-07$50.09/sh−9,500$475,855→ 10,500 total - Sale
Class A Common Stock
2018-08-08$49.82/sh−10,000$498,200→ 0 total - Conversion
Class A Common Stock
2018-08-07+12,000→ 20,000 total - Sale
Class A Common Stock
2018-08-07$50.60/sh−500$25,300→ 10,000 total
Footnotes (6)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.05 to $50.95, inclusive.
- [F3]Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.55 to $50.50, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.55 to $50.70, inclusive.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.55 to $50.30, inclusive.